文献速递浆细胞疾病

EMD源于剪切应力下透明质酸诱导的表达CD44变异体的多发性骨髓瘤细胞同型相互作用

EMD originates from hyaluronan-induced homophilic interactions of CD44 variant-expressing MM cells under shear stress.
PubMed 文献 · Blood Adv · 2023-01-01

本研究探讨多发性骨髓瘤(MM)髓外疾病(EMD)的发生机制。作者发现骨髓基质细胞来源的透明质酸(HA)在生理剪切应力下与MM细胞表面CD44(尤其长链变异体)结合,诱导细胞同型相互作用并形成细胞簇,可能发展为EMD。在同基因小鼠MM模型中,给予HA可CD44依赖性地重现EMD发生;HA诱导的MM细胞簇通过γ-分泌酶介导的CD44胞内域切割反式激活PI耐药诱导基因,体外和小鼠模型中均对蛋白酶体抑制剂(PIs)耐药。抗CD44抗体或γ-分泌酶抑制剂可抑制EMD发生并克服PI耐药、显著延长受体小鼠生存。

要点

  • 骨髓基质细胞来源的HA在生理剪切应力下与MM细胞表面CD44(尤其长链变异体)结合,诱导同型相互作用和细胞簇形成。
  • 同基因小鼠MM模型中给予HA可CD44依赖性地重现EMD发生。
  • 抗CD44抗体或γ-分泌酶抑制剂可抑制EMD发生并克服PI耐药,显著延长受体小鼠生存。

核心结论

  • HA-CD44轴是触发EMD发生的新通路,可能成为MM患者EMD预测、预防和治疗的靶点。

研究设计与样本

  • 研究采用同基因小鼠MM模型,并通过体外实验进行机制探讨。

主要发现

  • 骨髓基质细胞来源的HA在生理剪切应力下与MM细胞表面CD44(尤其长链变异体)结合,诱导同型相互作用并形成细胞簇,可能发展为EMD。
  • 在同基因小鼠MM模型中,给予HA可CD44依赖性地重现EMD发生。
  • HA诱导的MM细胞簇在体外和小鼠模型中通过γ-分泌酶介导的CD44胞内域切割反式激活PI耐药诱导基因,对PIs表现出特异性耐药。
  • 对注射HA的小鼠给予抗CD44抗体或γ-分泌酶抑制剂,可抑制移植MM细胞来源的EMD发生,并通过克服PI耐药显著延长受体小鼠生存。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Extramedullary disease (EMD) is known to be associated with chemoresistance and poor prognosis in multiple myeloma (MM); however, the mechanisms of its development are not fully understood. Elucidating the mechanism of EMD development and its therapeutic targeting would greatly contribute to further improvement of treatment outcome in patients with MM. Here, we show that bone marrow stroma cell-derived hyaluronan (HA) elicits homophilic interactions of MM cells by binding to surface CD44, especially long-stretch variants, under physiological shear stress and generates cell clusters that might develop into EMD. We recapitulated the development of EMD via administration of HA in a syngeneic murine MM model in a CD44-dependent manner. HA-induced MM cell clusters exhibited the specific resistance to proteasome inhibitors (PIs) in vitro and in murine models via γ-secretase-mediated cleavage of the intracellular domains of CD44, which in turn transactivated PI resistance-inducible genes. Treatment of HA-injected mice with anti-CD44 antibody or γ-secretase inhibitors readily suppressed the development of EMD from transplanted MM cells and significantly prolonged the survival of recipients by overcoming PI resistance. The HA-CD44 axis represents a novel pathway to trigger EMD development and could be a target of the prediction, prevention, and treatment of EMD in patients with MM.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Kikuchi J, Kodama N, Takeshita M, et al. EMD originates from hyaluronan-induced homophilic interactions of CD44 variant-expressing MM cells under shear stress. Blood Adv. 2023. PMID: 35930695. doi:10.1182/bloodadvances.2022007291

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。